Lymphatic vessels as targets of tumor therapy?
Karpanen
T
T
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, and Helsinki University Hospital, Helsinki 00014, Finland.
Alitalo
K
K
D000818:Animals; D015415:Biomarkers; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D015870:Gene Expression; D006023:Glycoproteins / Q000235:genetics; D006801:Humans; D008208:Lymphatic System / Q000166:cytology / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000235:genetics; D009088:Mucoproteins / Q000235:genetics; D009369:Neoplasms / Q000188:drug therapy*; D009389:Neovascularization, Pathologic; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D017978:Receptors, Growth Factor / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D042582:Vascular Endothelial Growth Factor C; D042643:Vascular Endothelial Growth Factor D; D040321:Vascular Endothelial Growth Factor Receptor-3; D033921:Vesicular Transport Proteins; D000098853:Podoplanin
D015415:Biomarkers; D016228:Endothelial Growth Factors; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D009088:Mucoproteins; D020794:Receptor Protein-Tyrosine Kinases; D017978:Receptors, Growth Factor; D042582:Vascular Endothelial Growth Factor C; D042643:Vascular Endothelial Growth Factor D; D040321:Vascular Endothelial Growth Factor Receptor-3; D033921:Vesicular Transport Proteins; C119248:LYVE1 protein, human; C117468:PDPN protein, human; D000098853:Podoplanin